The Catalyst, June 2023

The latest innovation news from the Oxford ecosystem.

Welcome to The Catalyst. In this edition we feature Beacon Therapeutics, a leading ophthalmic gene therapy company, securing a ground-breaking £96m seed investment to pioneer transformative gene therapies for retinal diseases, offering hope in restoring sight and shaping a brighter future.

View newsletter